Your Article Summary
Exonuclease Removal of Dideoxycytidine (Zalcitabine) by the Human Mitochondrial DNA Polymerase
Antimicrobial Agents and Chemotherapy, 01/17/08
Hanes JW et al. - In addition, we provide a more accurate measurement of the rate of excision and show that the low rate of removal of ddCMP results from both the unfavorable transfer of the primer strand from the polymerase to the exonuclease site and the inefficient binding and/or hydrolysis at the exonuclease site. The analogs ddC, stavudine, and ddATP (a metabolite of didanosine) each bind more tightly at the polymerase site during incorporation than normal nucleotides, and this tight binding contributes to slower excision by the proofreading exonuclease, leading to increased toxicity toward mitochondrial DNA
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential for False Resistance to Pyrazinamide when Using the BACTEC MGIT 960 System for Susceptibility Testing of M. tuberculosis
Journal of Clinical Microbiology, 12/02/09
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Infection Control and Hospital Epidemiology, 12/02/09
Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature
Canadian Journal of Surgery, 12/02/09

See Latest Articles